Video

The Evolving Specialty Pharmacy Model

John Musil, PharmD, chief executive officer and founder of Avella Specialty Pharmacy, discusses how the specialty pharmacy model is evolving.

John Musil, PharmD, chief executive officer and founder of Avella Specialty Pharmacy, discusses how the specialty pharmacy model is evolving.

This video was shot at the Armada Health Care 2014 Specialty Pharmacy Summit and Expo in Las Vegas, Nevada.

Related Videos
October is American Pharmacists Month.
American Pharmacist Month | Image Credit: Zoran Zeremski - stock.adobe.com
smiling indian male doctor or pharmacist in white coat with stethoscope and clipboard over drugstore background
Patient receiving cancer care from provider -- Image credit: Rido | stock.adobe.com
Patient taking prescription medicine -- Image credit: Rawpixel.com | stock.adobe.com
Artificial intelligence in health care -- Image credit: Martinesku | stock.adobe.com
Efficient healthcare supply chain management ensures timely delivery of medical supplies and medications
Pharmacy School, social media, non-traditional learning | Image Credit: Ахтем - stock.adobe.com
Children's doctor vaccinating little boy at home.
Image Credit: © jarun011 - stock.adobe.com
Related Content
Eye of the Beholder: Understanding The Subjective Experience of Acute Ketamine Treatment
October 4th 2024

Eye of the Beholder: Understanding The Subjective Experience of Acute Ketamine Treatment

Jack Vinciguerra, PharmD
Pharmacy Focus - Oncology Edition: Advancing Brain Cancer Research and Treatment
September 26th 2024

Pharmacy Focus - Oncology Edition: Advancing Brain Cancer Research and Treatment

Danon Disease, FDA, Orphan Drug Designation | Image Credit: C Davids/peopleimages.com - stock.adobe.com
October 3rd 2024

FDA Grants Orphan Drug Designation to PPL-002 for the Treatment of Danon Disease

Ashley Gallagher, Associate Editor
Public Health Matters podcast logo
September 19th 2024

Public Health Matters: The Difference Between Misinformation and Disinformation, and How Information Can Inform Evidence-Based Decisions

Photomicrograph of liver biopsy in a patient with cirrhosis, showing bridging septal fibrosis and regenerative nodules.
October 2nd 2024

FDA Grants Denifanstat Breakthrough Therapy Designation for Treatment of MASH

Luke Halpern, Assistant Editor
FDA Rare Pediatric Disease Designation | Image Credit: Trsakaoe - stock.adobe.com
October 1st 2024

FDA Grants Rare Pediatric Disease Designation to BPM31510IV for Primary CoQ10 Deficiency

Ashley Gallagher, Associate Editor